Crush The Market

undefined Logo

Geron Corporation

2.29 USD

-0.43%

Add To Watchlist

Symbol

GERN

Market Cap

873.028 Million USD

Sector

Healthcare

Description

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.

Website

https://www.geron.com

Crush The Market

We Use Cookies